【Labcorp、アルツハイマー病向け初のFDA承認血液検査を全米展開】

✔ FDA初承認のアルツハイマー病向け血液検査（IVD）
✔ 陽性的中率92%、陰性的中率97%の高精度
✔ 全米2,200か所のLabcorpセンターで提供開始
✔ 50歳以上の認知機能低下を示す成人が対象

#Labcorp #Fujirebio #Lumipulse #Alzheimers #pTau217 #BetaAmyloid42 #FDA承認 #体外診断 #認知症 #医療DX #PrecisionMedicine

FDA Approves Revolutionary Blood Test for Alzheimer's Diagnosis, Transforming Patient Care The FDA has granted approval for the Lumipulse blood test, a groundbreaking tool in the early diagnosis of Alzheimer's disease, enhancing patient care significantly.

FDA Approves Revolutionary Blood Test for Alzheimer's Diagnosis, Transforming Patient Care #USA #New_York #ADDF #Alzheimer's_Test #Lumipulse